From November 22, Bharat Biotech's Covaxin, one of the vaccines being given in India to protect against Covid-19, has been put on the UK’s list of approved vaccines for international travellers.
It comes as a major relief for fully vaccinated international travelers, especially Indians, planning travel to the UK without the need for a pre-departure RT-PCR test or self-isolation at the address declared on their compulsory passenger locator forms.
Like other fully vaccinated travellers, including those vaccinated with Covishield, Indian travellers are required to pre-book a RT-PCR or Lateral Flow Test on arrival in England, to be taken before the end of Day 2.
“From 4 am on Monday 22 November, the government will recognise vaccines on the World Health Organisation’s Emergency Use Listing (WHO EUL) at the border,” the UK’s Department for Transport confirmed.
“As a result, Sinovac, Sinopharm Beijing and Covaxin will be added to our existing list of approved vaccine for inbound travel, benefitting more fully vaccinated passengers,” it said.
Earlier, Bharat Biotech's Covaxin had received its WHO EUL status, resulting in the UK announcing plans to include it on its list of approved Covid vaccines from November 22.
-PTC News with agency inputs